Cocarboxylase

Cocarboxylase

SCHEMBL21111

Cc1ncc(C[n+]2csc(CCOP(=O)(O)OP(=O)(O)O)c2C)c(N)n1.[Cl-]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Cocarboxylase. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.98
TKT P29401 7/20 0.84
TDP1 Q9NUW8 1/20 0.84
HSP90AA1 P07900 1/20 0.63
ALDH1A1 P00352 2/20 0.57
KDM4E B2RXH2 1/20 0.53
PPP5C P53041 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cocarboxylase SCHEMBL8923435 1.00 LMNA (0.98) LMNATKTTDP1HSP90AA1ALDH1A1
Cocarboxylase SCHEMBL344290 0.99 LMNA (0.96) LMNATKTTDP1HSP90AA1ALDH1A1
Cocarboxylase SCHEMBL23151784 0.99 LMNA (0.96) LMNATKTTDP1HSP90AA1ALDH1A1
Cocarboxylase SCHEMBL662896 0.99 LMNA (0.96) LMNATKTTDP1HSP90AA1ALDH1A1
Cocarboxylase SCHEMBL30192281 0.99 LMNA (1.00) LMNATKTTDP1HSP90AA1ALDH1A1
Cocarboxylase SCHEMBL80028 0.99 LMNA (1.00) LMNATKTTDP1HSP90AA1ALDH1A1
Hydrochloric Acid SCHEMBL478202 0.98 LMNA (0.94) LMNATKTTDP1HSP90AA1ALDH1A1
Hydrochloric Acid SCHEMBL9766249 0.98 LMNA (0.94) LMNATKTTDP1HSP90AA1ALDH1A1
Cocarboxylase SCHEMBL23151785 0.98 LMNA (0.98) LMNATKTTDP1HSP90AA1ALDH1A1
Cocarboxylase SCHEMBL28619966 0.98 LMNA (0.98) LMNATKTTDP1HSP90AA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8913 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
CN-122079280-A 3D printing internal drawing conical solar interface evaporator with directional salt formation function and preparation method and application thereof 2026-05-26 CN claimed
CN-122056386-A Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-19 CN claimed
CN-121380249-B Method for preparing 2' -methoxy-uridine triphosphate 泰兴合全药业有限公司 2026-05-15 CN claimed
CN-122030612-A Shear-resistant slow-release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-15 CN claimed
CN-122012314-A Novel intestinal probiotics butyric acid monad and application thereof 青岛大学 2026-05-12 CN claimed
WO-2026087508-A1 HYDROGELS CONTAINING COVALENTLY LINKED COFACTORS AND METHODS FOR PREPARING THE SAME HELMHOLTZ ZENTRUM MÜNCHEN DEUTSCHES FORSCHUNGSZENTRUM FÜR GESUNDHEIT UND UMWELT (GMBH) (DE) 2026-04-30 WO claimed
EP-4698567-A1 HYDROGELS CONTAINING COVALENTLY LINKED COFACTORS AND METHODS FOR PREPARING THE SAME Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2026-02-25 EP claimed
US-20260022411-A1 MICROBIAL CELL FACTORIES PRODUCING THIAMINE BIOSYNTIA APS (DK) 2026-01-22 US claimed
US-12509707-B2 Methods for organic acid production S&P INGREDIENT DEVELOPMENT, LLC (US) 2025-12-30 US claimed
EP-0133694-A2 Process for producing neuraminidase and method and reagent for the quantitative determination of a sialic acid-containing substance using neuraminidase KYOWA HAKKO KOGYO CO., LTD. (JP) 1985-03-06 EP claimed
US-4503145-A DIAGNOSIS OF LIVER DISORDERS FUJI PHOTO FILM CO., LTD. (JP) 1985-03-05 US claimed
EP-0127012-A2 Antimutagenic agent and a method of reducing mutagenicity SUNTORY LIMITED (JP) 1984-12-05 EP claimed
EP-0121254-A2 Process for determining substrate or enzymatic activity WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1984-10-10 EP claimed
EP-0100413-A1 Method and preparation for the determination of glutamic-oxalacetic transaminase activity Roche Diagnostics GmbH (DE) 1984-02-15 EP claimed
EP-0076647-A2 Culture media for cells originating from the immune system HANA Biologics Incorporated (US) 1983-04-13 EP claimed
US-4372874-A Stabilization of hydrolysis prone labile organic reagents in liquid media MEDICAL ANALYSIS SYSTEMS, INC. 1983-02-08 US claimed
US-4246342-A BACTERIAL BIOSYNTHESIS, USE IN DETERMINATION OF PYRUVIC ACID TOYO JOZO KABUSHIKI KAISHA (JP) 1981-01-20 US claimed
US-4237229-A CONTACTING A PROTEIN, ENZYME, COENZYME, OR ANTIBIOTIC WITH AN ISOCYANATE-CAPPED POLYETHERURETHANE COPOLYMER, SHAPING, AND CURING W. R. GRACE & CO. (US) 1980-12-02 US claimed
US-4006223-A Drug composition intended for the treatment of acute, lethal and chronic radiation disease SPITALUL CLINIC FILANTROPIA BUCURESTI (RU) 1977-02-01 US claimed